Alpha-adrenergic blockade
Angiotensin-converting enzyme activation
Cyclooxygenase inhibition
Dopamine receptor agonism
Off-label use
Inverse agonists
Beta-adrenergic receptors
Loop diuretics
Codeine
Drug metabolism
Constipation
Antagonist
Bioavailability
Bacteriostatic agent
Full agonist
First-pass metabolism
Mu-opioid receptors
Persistent dry cough
Synergism
Serotonin
Kidney
Half-life
Tolerance
Pharmacogenomics
Therapeutic index
CYP3A4
Phase I clinical trial
Volume of distribution
